CH
IMUX icon

CVI Holdings’s Immunic IMUX Stock Holding History

CVI Holdings’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16,295
Closed -$1.98M – 101
2020
Q2 		$1.98M Buy
+16,295
New +$1.66M 0.73% 26

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

CVI Holdings's IMUX Position: Q3 2020 in Review

CVI Holdings sold out of Immunic (IMUX) in Q3 2020, closing a stake of 16,295 shares — an estimated $1.98M sold.

CVI Holdings first reported a position in IMUX in Q2 2020 and held it in 1 quarter. The position peaked at $1.98M in Q2 2020. 66 funds tracked by Wall St. Rank hold IMUX as of Q3 2020.

  • CVI Holdings reported no remaining Immunic position as of Q3 2020 after selling out during the quarter.
  • CVI Holdings sold 16,295 Immunic shares in Q3 2020, an estimated $1.98M.
  • CVI Holdings first reported a position in Immunic in Q2 2020 and held it in 1 quarter.
  • CVI Holdings's Immunic position peaked at $1.98M in Q2 2020.
  • 66 funds tracked by Wall St. Rank held Immunic as of Q3 2020.

Based on CVI Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.